Print this page
 Email this page

 Connect with UMMC on:
 Twitter
 Facebook
 YouTube
iPhone

 Share this page:

Bookmark and Share

Home > Medical Reference > Encyclopedia (English)



 

Video details

[ Flash player icon ] Please install flash player to see this video.

Hospital Virtual Tour

Click to take a virtual tour

Related Content


 

U.S. Brand Names:

Capozide®

Synonyms:

Hydrochlorothiazide and Captopril

Generic Available:

Yes

Canadian Brand Names:

Capozide®

Use:

Management of hypertension and treatment of congestive heart failure

Pregnancy Risk Factor:

C/D (2nd and 3rd trimesters)

Pregnancy Implications:

See individual monographs.

Lactation:

Enters breast milk/compatible

Contraindications:

Hypersensitivity to captopril, hydrochlorothiazide, or any component of the formulation; pregnancy (2nd and 3rd trimesters)

Adverse Reactions:

See individual agents.

Drug Interactions:

Captopril: Substrate of CYP2D6 (major)

Also see individual agents.

Mechanism of Action:

Captopril is a competitive inhibitor of angiotensin-converting enzyme (ACE); prevents conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. This results in lower levels of angiotensin II which causes an increase in plasma renin activity and a reduction in aldosterone secretion. Hydrochlorothiazide inhibits sodium reabsorption in the distal tubules causing increased excretion of sodium and water as well as potassium and hydrogen ions.

Pharmacodynamics/Kinetics:

See individual agents.

Dosage:

Oral: Adults: Hypertension, CHF: May be substituted for previously titrated dosages of the individual components; alternatively, may initiate as follows:

Initial: Single tablet (captopril 25 mg/hydrochlorothiazide 15 mg) taken once daily; daily dose of captopril should not exceed 150 mg; daily dose of hydrochlorothiazide should not exceed 50 mg

Patient Education:

See individual agents. Pregnancy precaution: Inform prescriber if you are or intend to become pregnant.

Cardiovascular Considerations:

Combination therapy for the treatment of hypertension should be individualized for each patient. Potential advantages for captopril and hydrochlorothiazide combination therapy may include improved compliance and synergistic reductions in blood pressure with an accomplished reduction in side effects. See Special Cardiovascular Considerations for individual agents.

Dental Health: Effects on Dental Treatment:

No significant effects or complications reported

Dental Health: Vasoconstrictor/Local Anesthetic Precautions:

No information available to require special precautions

Mental Health: Effects on Mental Status:

May cause drowsiness or insomnia

Mental Health: Effects on Psychiatric Treatment:

May rarely cause agranulocytosis; use caution with clozapine and carbamazepine; may decrease lithium clearance resulting in an increase in serum lithium levels and potential lithium toxicity; monitor serum lithium levels

Dosage Forms:

Tablet:

25/15: Captopril 25 mg and hydrochlorothiazide 15 mg

25/25: Captopril 25 mg and hydrochlorothiazide 25 mg

50/15: Captopril 50 mg and hydrochlorothiazide 15 mg

50/25: Captopril 50 mg and hydrochlorothiazide 25 mg

International Brand Names:

Capozide® (CA)

References

Chobanian AV, Bakris GL, Black HR, et al, "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report,"JAMA, 2003, 289(19):2560-71.

Kaplan NM and Sever PS, "Combination Therapy: A Key to Comprehensive Patient Care,"Am J Hypertens, 1997, 10(7 Pt 2):127S.

Moser M and Black HR, "The Role of Combination Therapy in the Treatment of Hypertension,"Am J Hypertens, 1998, 11(6 Pt 2):73S-8S, 95S-100S.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com